Clinical Trial Update: Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of Auger Molecular Therapy (AMT) for malignant cutaneous lesions is currently recruiting, sponsored by NanoRay Biotech Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Fungating Wounds

Drugs mentioned

• Auger Molecular Therapy (AMT)

Snippet

Sponsor: NanoRay Biotech Co., Ltd. | Conditions: Malignant Fungating Wound | Phase 1, Phase 2 | Status: RECRUITING